The activin A antagonist follistatin inhibits asthmatic airway remodelling

Abstract

These data demonstrate that follistatin attenuates asthmatic airway remodelling. Our findings point to the potential of follistatin as a therapeutic for prevention of airway remodelling in asthma and other inflammatory lung diseases.